Atrial Fibrillation/flutter Hospitalizations among US Medicaid Recipients with and without Systemic Lupus Erythematosus

被引:12
|
作者
Chen, Sarah K. [1 ]
Barbhaiya, Medha [5 ]
Solomon, Daniel H. [1 ,2 ]
Guan, Hongshu [1 ]
Yoshida, Kazuki [1 ]
Feldman, Candace H. [1 ]
Everett, Brendan M. [3 ,4 ]
Costenbader, Karen H. [1 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Med, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA
[5] Hosp Special Surg, Dept Med, Div Rheumatol, 535 E 70th St, New York, NY 10021 USA
基金
美国国家卫生研究院;
关键词
SYSTEMIC LUPUS ERYTHEMATOSUS; CARDIOVASCULAR DISEASE; ATRIAL FIBRILLATION; MEDICAID; ACUTE MYOCARDIAL-INFARCTION; RISK-FACTORS; ADMINISTRATIVE DATA; STROKE; DISEASE; IDENTIFICATION; INFLAMMATION; VALIDATION; ALGORITHMS; ICD-9-CM;
D O I
10.3899/jrheum.190502
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Systemic lupus erythematosus (SLE) is a multisystem chronic inflammatory autoimmune disease with high prevalence of several risk factors for atrial fibrillation/flutter (AF). However, the incidence and risk of AF in SLE have not been well quantified. Methods. We used the United States Medicaid Analytic eXtract from 2007 to 2010 to identify beneficiaries aged 18-65 years, with prevalent SLE, each matched by age and sex to 4 non-SLE general Medicaid recipients. We estimated the incidence rates (IR) per 1000 person-years (PY) for AF hospitalizations and used multivariable Cox regression to estimate the HR for AF hospitalization. Results. We identified 46,876 US Medicaid recipients with SLE, and 187,504 age-and sex-matched non-SLE controls (93% female; mean age 41.5 +/- 12.2 yrs). Known AF risk factors such as hypertension (HTN), cardiovascular disease (CVD), and kidney disease were more prevalent in patients with SLE. During a mean followup of 1.9 +/- 1.1 years for SLE, and 1.8 +/- 1.1 years for controls, the IR per 1000 PY for AF was 1.4 (95% CI 1.1-1.6) among patients with SLE and 0.7 (95% CI 0.6-0.8) among non-SLE controls. In age-and sex-matched and race-adjusted Cox models, the HR for AF was 1.79 (95% CI 1.43-2.24); after adjustment for baseline HTN and CVD, the adjusted HR was reduced to 1.17 (95% CI 0.92-1.48). Conclusion. SLE was associated with a doubled rate of hospitalization for AF compared to age-and sex-matched general Medicaid patients. In a race-adjusted model, the risk was 80% higher. However, the AF risk factors HTN and CVD were more prevalent among patients with SLE and accounted for the excess risk.
引用
收藏
页码:1359 / 1365
页数:7
相关论文
共 50 条
  • [41] Prediction of Hospitalizations in Systemic Lupus Erythematosus Using a Frailty Index
    Legge, Alexandra
    Kirkland, Susan
    Rockwood, Kenneth
    Andreou, Pastelis
    Hanly, John
    [J]. JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1068 - 1068
  • [42] Characterizing primary hospitalizations for systemic lupus erythematosus in the United States
    Desai, Amar D.
    Werth, Victoria P.
    Elman, Scott A.
    [J]. RHEUMATOLOGY, 2023, 62 (12) : E335 - E337
  • [43] Racial Differences in Contraception Encounters and Dispensing Among Female Medicaid Beneficiaries With Systemic Lupus Erythematosus
    Williams, Jessica N.
    Xu, Chang
    Costenbader, Karen H.
    Bermas, Bonnie L.
    Pace, Lydia E.
    Feldman, Candace H.
    [J]. ARTHRITIS CARE & RESEARCH, 2021, 73 (10) : 1396 - 1404
  • [44] Azathioprine and Mycophenolate Mofetil Adherence Patterns and Predictors Among Medicaid Beneficiaries With Systemic Lupus Erythematosus
    Feldman, Candace H.
    Collins, Jamie
    Zhang, Zhi
    Xu, Chang
    Subramanian, S. V.
    Kawachi, Ichiro
    Solomon, Daniel H.
    Costenbader, Karen H.
    [J]. ARTHRITIS CARE & RESEARCH, 2019, 71 (11) : 1419 - 1424
  • [45] Epidemiology and Sociodemographic Distribution of Upper Gastrointestinal Bleeding Among Medicaid Beneficiaries with Systemic Lupus Erythematosus
    Xu, Chang
    Perencevich, Molly
    Kim, Seoyoung
    Costenbader, Karen
    Feldman, Candace
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [46] Disparities in Psychiatric Diagnosis and Treatment for Youth with Systemic Lupus Erythematosus: Analysis of a National US Medicaid Sample
    Knight, Andrea M.
    Xie, Ming
    Mandell, David S.
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (07) : 1427 - 1433
  • [47] CHARACTERIZATION OF COMORBIDITIES AND ECONOMIC BURDEN IN US MEDICARE BENEFICIARIES WITH SYSTEMIC LUPUS ERYTHEMATOSUS WITH AND WITHOUT LUPUS NEPHRITIS
    Nair, A.
    Wilson, B.
    Buser, H.
    Gerstley, H.
    Ricci, J. F.
    Delise, B.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S523 - S523
  • [48] The cost of flares among patients with systemic lupus erythematosus with and without lupus nephritis in the United States
    Bell, Christopher F.
    Huang, Shirley P.
    Cyhaniuk, Anissa
    Averell, Carlyne M.
    [J]. LUPUS, 2023, 32 (02) : 301 - 309
  • [50] Systemic lupus erythematosus is a risk factor for atrial fibrillation: a nationwide, population-based study
    Lim, S. Y.
    Bae, E. H.
    Han, K. -D.
    Jung, J. -H.
    Choi, H. S.
    Kim, C. S.
    Ma, S. K.
    Kim, S. W.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (06) : 1019 - 1025